Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM)

88 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.5M shares of 22.1M outstanding shares and own 61.08% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (3.06M shares), Principia Wealth Advisory, LLC (2.03M shares), TCG Crossover Management, LLC (1.8M shares), Frazier Life Sciences Management, L.P. (1.07M shares), VANGUARD GROUP INC (884K shares), RENAISSANCE TECHNOLOGIES LLC (571K shares), 5AM Venture Management, LLC (542K shares), GOLDMAN SACHS GROUP INC (497K shares), BlackRock, Inc. (414K shares), and Pale Fire Capital SE (359K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.